These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 10493131
1. Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera. Sanchez-Campillo M, Bini L, Comanducci M, Raggiaschi R, Marzocchi B, Pallini V, Ratti G. Electrophoresis; 1999 Aug; 20(11):2269-79. PubMed ID: 10493131 [Abstract] [Full Text] [Related]
2. Mapping of Chlamydia trachomatis proteins by immobiline-polyacrylamide two-dimensional electrophoresis: spot identification by N-terminal sequencing and immunoblotting. Bini L, Sanchez-Campillo M, Santucci A, Magi B, Marzocchi B, Comanducci M, Christiansen G, Birkelund S, Cevenini R, Vretou E, Ratti G, Pallini V. Electrophoresis; 1996 Jan; 17(1):185-90. PubMed ID: 8907538 [Abstract] [Full Text] [Related]
5. Identification and characterization of Brucella ovis immunogenic proteins using two-dimensional electrophoresis and immunoblotting. Teixeira-Gomes AP, Cloeckaert A, Bézard G, Bowden RA, Dubray G, Zygmunt MS. Electrophoresis; 1997 Aug; 18(8):1491-7. PubMed ID: 9298663 [Abstract] [Full Text] [Related]
6. Identification of an iron-responsive protein that is antigenic in patients with Chlamydia trachomatis genital infections. Raulston JE, Miller JD, Davis CH, Schell M, Baldwin A, Ferguson K, Lane H. FEMS Immunol Med Microbiol; 2007 Dec; 51(3):569-76. PubMed ID: 17991015 [Abstract] [Full Text] [Related]
7. Serological response to pgp3 protein in animal and human chlamydial infections. Donati M, Laroucau K, Storni E, Mazzeo C, Magnino S, Di Francesco A, Baldelli R, Ceglie L, Renzi M, Cevenini R. Vet Microbiol; 2009 Mar 16; 135(1-2):181-5. PubMed ID: 18945555 [Abstract] [Full Text] [Related]
8. In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB. Barker CJ, Beagley KW, Hafner LM, Timms P. Vaccine; 2008 Mar 04; 26(10):1285-96. PubMed ID: 18261829 [Abstract] [Full Text] [Related]
9. Expression of two novel proteins in Chlamydia trachomatis during natural infection. Myers GS, Grinvalds R, Booth S, Hutton SI, Binks M, Kemp DJ, Sriprakash KS. Microb Pathog; 2000 Aug 04; 29(2):63-72. PubMed ID: 10906261 [Abstract] [Full Text] [Related]
14. Human antibody and antigen response to IncA antibody of Chlamydia trachomatis. Tsai PY, Hsu MC, Huang CT, Li SY. Int J Immunopathol Pharmacol; 2007 Aug 04; 20(1):156-61. PubMed ID: 17346439 [Abstract] [Full Text] [Related]
15. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection. Singh SR, Hulett K, Pillai SR, Dennis VA, Oh MK, Scissum-Gunn K. Vaccine; 2006 Feb 20; 24(8):1213-24. PubMed ID: 16194585 [Abstract] [Full Text] [Related]
17. Capture-ELISA: a new assay for the detection of immunoglobulin M isotype antibodies using Chlamydia trachomatis antigen. Poussin M, Fuentes V, Corbel C, Prin L, Eb F, Orfila J. J Immunol Methods; 1997 May 12; 204(1):1-12. PubMed ID: 9202704 [Abstract] [Full Text] [Related]
20. Characterization of the disulfide bonds and free cysteine residues of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein. Yen TY, Pal S, de la Maza LM. Biochemistry; 2005 Apr 26; 44(16):6250-6. PubMed ID: 15835913 [Abstract] [Full Text] [Related] Page: [Next] [New Search]